Ink4c is dispensable for tumor suppression in Myc-induced B-cell lymphomagenesis

L M Nilsson1, U B Keller, C Yang

  • 1Department of Biochemistry, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.

Oncogene
|November 14, 2006
PubMed

Insights

The tumor suppressor p18 (Inhibitor of cyclin-dependent kinase 4c) loss did not affect lymphoma onset in Emu-Myc mice. However, it reduced the frequency of Arf loss, a common event in these B-cell lymphomas.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • p18(Ink4c) is a cyclin-dependent kinase inhibitor that suppresses tumor development.
  • Loss of Ink4c predisposes mice to tumors and enhances oncogene effects.
  • The Emu-Myc transgenic mouse model mimics human Burkitt lymphoma.

Purpose of the Study:

  • To investigate the impact of Ink4c loss on B-cell tumor development in the Emu-Myc mouse model.
  • To determine if Ink4c deficiency influences lymphoma onset or progression.
  • To analyze the interplay between Ink4c, Myc, and Arf in B-cell lymphomagenesis.

Main Methods:

  • Utilized Emu-Myc transgenic mice with varying Ink4c allelic status (wild-type, heterozygous, homozygous null).
  • Monitored lymphoma onset and progression in these mouse cohorts.
  • Assessed proliferative and apoptotic responses in precancerous B cells.
  • Quantified the frequency of Arf loss in developed lymphomas.

Main Results:

  • Loss of one or both Ink4c alleles did not alter the onset of lymphoma in Emu-Myc transgenics.
  • Ink4c deficiency did not significantly affect Myc-driven proliferation or apoptosis in early B cells.
  • Ink4c loss significantly decreased the frequency of Arf loss in Emu-Myc lymphomas.

Conclusions:

  • Ink4c is not a critical determinant for lymphoma initiation in the Emu-Myc model.
  • Ink4c modulates Myc-induced transformation by influencing alternative genetic events, specifically reducing Arf loss.
  • This suggests a complex role for Ink4c in tumor suppression beyond direct cell cycle inhibition, potentially by impacting the selection of cooperating genetic alterations.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...